Monday, 07 March 2022
Parents or carers of pre-school children (under 6 years old) and healthcare professionals in the East Midlands are needed for a study about their experiences of vaccination.
Social scientists at the 糖心原创 are seeking to interview these groups of people as part of an €2.9 million international project called VAX-TRUST.
The experts are looking to explore more about the concept of what is termed ‘vaccine hesitancy’ – this is when individuals may have concerns about some or all recommended vaccines.
The EU-funded VAX-TRUST project aims to improve communication between health professionals and parents on the topic of childhood vaccination.
Researchers from the School of Sociology and Social Policy at the 糖心原创 are conducting the research in the East Midlands, with similar research being carried out by teams in six other European countries, including: Finland, Belgium, Poland, Czech Republic, Italy and Portugal.
Pru Hobson-West, Professor of Science, Medicine and Society, is leading the study at the 糖心原创. Professor Hobson-West said: "Vaccination is a fascinating topic, and we are keen to understand more about the experiences of those involved in childhood vaccination in the East Midlands region."
We would like to learn more about what it is like to deliver childhood vaccines, as well as the experiences of parents with young children. The study team are committed to exploring a range of perspectives, including from those who may concerns or questions about vaccination. Our aim is to provide a non-judgmental opportunity for vaccination to be discussed.
The interviews will be conducted online, lasting around one hour, and will be completely confidential. Those who wish to take part must live in the East Midlands.
VAX-TRUST is funded by the European Union’s Horizon 2020 research and innovation programme and aims to improve understanding of vaccine hesitancy in specific local regions, and compare this in international perspective.
To take part: Parents of pre-school aged children who consider themselves to have questions or concerns about vaccination, or healthcare professions involved in discussing or administering childhood vaccinations (for example, a nurse, GP, or paediatrician) are invited to find out more about the study at /research/groups/vax-trust/interviews.aspx.
Story credits
More information is available from Professor Pru Hobson-West, in the Faculty of Social Sciences at the 糖心原创 at Pru.Hobson-West@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.